Related Experiment Video
Updated: Dec 5, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Cobalt(III) Schiff base complexes stabilize non-fibrillar amyloid-β aggregates with reduced toxicity
Kaleigh F Roberts1, Christopher R Brue1, Anna Preston1
1Departments of Chemistry, Molecular Biosciences, Neurobiology, and Radiology, Northwestern University, Evanston, IL 60208, United States.
Cobalt(III) Schiff base complexes (Co(III)-sb) were investigated for their effect on amyloid-beta (Aβ) aggregation, a key factor in Alzheimer's disease. Co(III)-sb was found to reduce Aβ cytotoxicity by altering aggregation kinetics.
Area of Science:
- Biochemistry
- Neuroscience
- Materials Science
Background:
- Amyloid-beta (Aβ) aggregation is central to Alzheimer's disease (AD) pathogenesis.
- In vitro Aβ aggregation kinetics serve as a biomarker for disease progression and a target for therapeutics.
Purpose of the Study:
- To investigate the effect of cobalt(III) Schiff base complex (Co(III)-sb) on Aβ aggregation kinetics.
- To determine the mechanism by which Co(III)-sb modulates Aβ aggregation.
- To assess the impact of Co(III)-sb on the cytotoxicity of Aβ aggregates.
Main Methods:
- Utilized Thioflavin T (ThT) fluorescence, circular dichroism (CD) spectroscopy, transmission electron microscopy (TEM), and atomic force microscopy (AFM).
- Applied a mathematical model by Knowles et al. to kinetic data for mechanistic analysis.
- Quantified cytotoxicity of Aβ aggregates formed with and without Co(III)-sb.
Main Results:
- Co(III)-sb decreased Aβ polymerization rate and increased nucleation rate.
- Co(III)-sb promotes rapid stabilization of oligomeric Aβ species, inhibiting fibril elongation.
- Aβ aggregates formed with Co(III)-sb showed reduced cytotoxicity compared to controls.
Conclusions:
- Co(III)-sb effectively modulates Aβ aggregation kinetics, offering a potential therapeutic strategy for Alzheimer's disease.
- The complex stabilizes toxic oligomeric intermediates, reducing overall fibril formation and cytotoxicity.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Complexation Equilibria: Factors Influencing Stability of Complexes
Colors and Magnetism
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human...
Valence Bond Theory
Complexation Equilibria: The Chelate Effect

